Literature DB >> 31785021

Body mass index, diabetes, and the risk of Parkinson's disease.

Su-Min Jeong1,2, Kyungdo Han3, Dahye Kim3, Sang Youl Rhee4,5, Wooyoung Jang6, Dong Wook Shin1,7,8.   

Abstract

BACKGROUND: There are conflicting findings in the literature regarding the association of body mass index and incidence of PD.
OBJECTIVES: This study aimed to investigate the association of body mass index with the risk of PD incidence while considering diabetes mellitus as a major confounding factor.
METHODS: We examined 6,800,601 individuals (aged ≥40 years) who were free of PD using the database of the Korean National Health Insurance Service. Cox proportional hazard regression was used to assess adjusted hazard ratios for PD with adjustment for potential confounders. Stratified analyses by diabetes status were also performed.
RESULTS: A total of 33,443 individuals were diagnosed with PD during the follow-up period (7.3 years). An increased risk of PD incidence was observed in the underweight group versus the normal group (adjusted hazard ratio: 1.28; 95% confidence interval: 1.21-1.36), whereas a decreased risk of PD incidence was observed (adjusted hazard ratio: 0.88; 95% confidence interval: 0.88-0.93) in the obese group and (adjusted hazard ratio: 0.77; 95% confidence interval: 0.72-0.82) in the severely obese group. This association consistently persisted after stratification by diabetes mellitus status, with the steepest downward slope for PD risk present with increasing body mass index in patients with severe diabetes mellitus (i.e., long duration or complication).
CONCLUSIONS: Being underweight and diabetes mellitus were associated with an increased risk of PD incidence, and effect of being underweight was more prominent in those with diabetes mellitus, with a dose-response relationship existing according to diabetes mellitus status. Further research is warranted to understand the clinical implications of the significant interaction between being underweight and diabetes mellitus status in the development of PD.
© 2020 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; body mass index; diabetes; underweight

Year:  2019        PMID: 31785021     DOI: 10.1002/mds.27922

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy.

Authors:  Su-Min Jeong; Taewoong Choi; Dahye Kim; Kyungdo Han; Seok Jin Kim; Sang Youl Rhee; Edward L Giovannucci; Dong Wook Shin
Journal:  Leukemia       Date:  2020-12-02       Impact factor: 11.528

Review 2.  Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.

Authors:  Sandeep Xxxx; Mir Hilal Ahmad; Linchi Rani; Amal Chandra Mondal
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

3.  Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real-World Cohort.

Authors:  David M Kent; Lester Y Leung; Eric J Puttock; Andy Y Wang; Patrick H Luetmer; David F Kallmes; Jason Nelson; Sunyang Fu; Chengyi Zheng; Ellen M Vickery; Hongfang Liu; Alastair J Noyce; Wansu Chen
Journal:  Ann Neurol       Date:  2022-08-17       Impact factor: 11.274

4.  Waist circumference and risk of Parkinson's disease.

Authors:  Kye-Yeung Park; Ga Eun Nam; Kyungdo Han; Hoon-Ki Park; Hwan-Sik Hwang
Journal:  NPJ Parkinsons Dis       Date:  2022-07-08

5.  Effects of dietary restriction on neuroinflammation in neurodegenerative diseases.

Authors:  Luigi Fontana; Laura Ghezzi; Anne H Cross; Laura Piccio
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

6.  Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.

Authors:  Iara Pérez-Taboada; Samuel Alberquilla; Eduardo D Martín; Rishi Anand; Stefania Vietti-Michelina; Nchimunya N Tebeka; James Cantley; Stephanie J Cragg; Rosario Moratalla; Mario Vallejo
Journal:  Mov Disord       Date:  2020-07-15       Impact factor: 10.338

7.  Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study.

Authors:  Hayoung Choi; Jung Eun Yoo; Kyungdo Han; Wonsuk Choi; Sang Youl Rhee; Hyun Lee; Dong Wook Shin
Journal:  Front Nutr       Date:  2021-12-01

8.  Attenuated Postprandial GLP-1 Response in Parkinson's Disease.

Authors:  Richard A Manfready; Phillip A Engen; Leo Verhagen Metman; Gabriella Sanzo; Christopher G Goetz; Deborah A Hall; Christopher B Forsyth; Shohreh Raeisi; Robin M Voigt; Ali Keshavarzian
Journal:  Front Neurosci       Date:  2021-07-02       Impact factor: 4.677

9.  Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.

Authors:  Ruth Brauer; Li Wei; Tiantian Ma; Dilan Athauda; Christine Girges; Nirosen Vijiaratnam; Grace Auld; Cate Whittlesea; Ian Wong; Tom Foltynie
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

10.  Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Xiaocui Qin; Xia Zhang; Pinyu Li; Min Wang; Li Yan; Zeqing Bao; Qili Liu
Journal:  Front Neurol       Date:  2021-07-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.